Search

Your search keyword '"Mirone,Vincenzo"' showing total 2,240 results

Search Constraints

Start Over You searched for: Author "Mirone,Vincenzo" Remove constraint Author: "Mirone,Vincenzo" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
2,240 results on '"Mirone,Vincenzo"'

Search Results

1. Functional and oncological outcomes after radical prostatectomy in patients with history of surgery for lower urinary tract symptoms related to benign prostatic enlargement: A systematic review with meta-analysis

4. Differences in future life expectancy of testicular germ-cell tumor patients vs. age-matched male population-based controls

5. Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors

7. Robotic assisted simple prostatectomy versus other treatment modalities for large benign prostatic hyperplasia: a systematic review and meta-analysis of over 6500 cases

13. Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study

25. Survival of stage III non‐seminoma testis cancer patients versus simulated controls, according to race/ethnicity.

27. Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis

29. Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor

30. Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy.

32. MP19-10 ADDITIONAL VALUE OF MRI IN PATIENTS WITH PSA >10 NG/ML AND/OR POSITIVE DRE: IS MRI ALWAYS NEEDED?

33. MP74-12 IMPACT OF MAGNETIC RESONANCE IMAGING SCAN AND IMAGE ACQUISITION PROTOCOL IN DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER AT BIOPSY: RESULTS FROM THE PROMOD WORKING GROUP

34. PD19-08 EAU RISK STRATIFICATION FOR PROSTATE CANCER ACCORDING TO SYSTEMATIC BIOPSY, TARGET BIOPSY AND COMBINED BIOPSY RESULTS AND FINAL PATHOLOGY CONCORDANCE. RESULTS FROM THE PROMOD STUDY GROUP

35. MP49-13 INTERCENTER VARIABILITY IN THE ACCURACY OF RISK CALCULATORS BASED ON MRI PARAMETERS: EXTENSIVE EXTERNAL VALIDATION OF 7 CONTEMPORARY RISK CALCULATORS

36. Long-Term Oncological Outcomes after Nerve-Sparing Robot-Assisted Radical Prostatectomy for High-Risk Localized Prostate Cancer: A Single-Center, Two-Arm Prospective Study

37. Telemedicine and social media: A contemporary analysis of the most shared content by internet users

39. Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer

41. Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer

42. Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer Center

45. Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies: Time to Improve Radiologists’ Training Program?

48. Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer

50. Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer

Catalog

Books, media, physical & digital resources